Jinwei Yuan

1.1k total citations
18 papers, 634 citations indexed

About

Jinwei Yuan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Jinwei Yuan has authored 18 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 5 papers in Nutrition and Dietetics. Recurrent topics in Jinwei Yuan's work include Potassium and Related Disorders (8 papers), Electrolyte and hormonal disorders (5 papers) and Magnesium in Health and Disease (4 papers). Jinwei Yuan is often cited by papers focused on Potassium and Related Disorders (8 papers), Electrolyte and hormonal disorders (5 papers) and Magnesium in Health and Disease (4 papers). Jinwei Yuan collaborates with scholars based in United States, China and United Kingdom. Jinwei Yuan's co-authors include Amanda E. Toland, Allan Balmain, Hiroki Nagase, Paraskevi Briassouli, Spiros Linardopoulos, John P. de Koning, Maria Rosário Almeida, Bruce A.J. Ponder, John Burn and Florence Chan and has published in prestigious journals such as Nature Genetics, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Jinwei Yuan

18 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinwei Yuan United States 11 311 162 154 152 81 18 634
Yang Qiu China 14 396 1.3× 97 0.6× 54 0.4× 137 0.9× 63 0.8× 43 809
Yuanyuan Xie China 14 221 0.7× 110 0.7× 23 0.1× 101 0.7× 30 0.4× 49 656
Rajalakshmi Veeranan‐Karmegam United States 14 385 1.2× 58 0.4× 49 0.3× 91 0.6× 23 0.3× 22 673
Lan Shen China 15 368 1.2× 98 0.6× 20 0.1× 93 0.6× 112 1.4× 38 638
Changsheng Xu China 16 320 1.0× 163 1.0× 36 0.2× 37 0.2× 10 0.1× 54 692
Paulina Podkalicka Poland 16 465 1.5× 25 0.2× 71 0.5× 23 0.2× 45 0.6× 26 596
Emilie Roudier Canada 16 427 1.4× 91 0.6× 68 0.4× 117 0.8× 6 0.1× 32 809
Natanael Zarco United States 15 208 0.7× 48 0.3× 53 0.3× 53 0.3× 13 0.2× 30 531

Countries citing papers authored by Jinwei Yuan

Since Specialization
Citations

This map shows the geographic impact of Jinwei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinwei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinwei Yuan more than expected).

Fields of papers citing papers by Jinwei Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinwei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinwei Yuan. The network helps show where Jinwei Yuan may publish in the future.

Co-authorship network of co-authors of Jinwei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Jinwei Yuan. A scholar is included among the top collaborators of Jinwei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinwei Yuan. Jinwei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Casale, Thomas B., Edwin W. Tucker, Jinwei Yuan, et al.. (2025). Initial results from BEACON, a phase 1b/2a dose escalation study of the anti-c-Kit briquilimab antibody in adults with chronic spontaneous urticaria (CSU). Journal of Allergy and Clinical Immunology. 155(2). AB435–AB435. 1 indexed citations
2.
Liu, Donglan, Dingding Gao, Jinwei Yuan, et al.. (2024). Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors. International Journal of Biological Macromolecules. 264(Pt 1). 130377–130377. 5 indexed citations
3.
Bushinsky, David A., et al.. (2023). Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials. American Journal of Kidney Diseases. 82(1). 97–104. 6 indexed citations
4.
Fu, Yuan, Jinwei Yuan, Yuting Yang, et al.. (2023). Fam72a functions as a cell-cycle-controlled gene during proliferation and antagonizes apoptosis through reprogramming PP2A substrates. Developmental Cell. 58(5). 398–415.e7. 9 indexed citations
5.
Liu, Wanhong, et al.. (2022). The NtNRAMP1 transporter is involved in cadmium and iron transport in tobacco (Nicotiana tabacum). Plant Physiology and Biochemistry. 173. 59–67. 45 indexed citations
6.
Yuan, Jinwei, Jianlong Li, Man Shang, Yuan Fu, & Ting Wang. (2021). Identification of vitamin B6 as a PD-L1 suppressor and an adjuvant for cancer immunotherapy. Biochemical and Biophysical Research Communications. 561. 187–194. 13 indexed citations
7.
Piña, Ileana L., et al.. (2020). Effect of patiromer on serum potassium in hyperkalemic patients with heart failure: Pooled analysis of 3 randomized trials. Progress in Cardiovascular Diseases. 63(5). 656–661. 4 indexed citations
8.
Bushinsky, David A., David M. Spiegel, Jinwei Yuan, et al.. (2018). Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral Metabolism. Clinical Journal of the American Society of Nephrology. 14(1). 103–110. 13 indexed citations
9.
Kloner, Robert A., Coleman Gross, Jinwei Yuan, Ansgar Conrad, & Pablo E. Pérgola. (2018). Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors. Journal of Cardiovascular Pharmacology and Therapeutics. 23(6). 524–531. 10 indexed citations
10.
Jin, Ziqi, Jian Hao, Xue Yang, et al.. (2018). Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2. Oncology Reports. 40(4). 2127–2136. 16 indexed citations
11.
Zhang, Xiaolan, Jinwei Yuan, Haoran Zhang, et al.. (2018). Cucurbitacin B inhibits the migration and invasion of breast cancer cells by altering the biomechanical properties of cells. Phytotherapy Research. 33(3). 618–630. 25 indexed citations
12.
Pérgola, Pablo E., David M. Spiegel, Suzette Warren, Jinwei Yuan, & Matthew R. Weir. (2017). Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study. American Journal of Nephrology. 46(4). 323–332. 29 indexed citations
13.
Weir, Matthew R., George L. Bakris, Coleman Gross, et al.. (2016). Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors. Kidney International. 90(3). 696–704. 50 indexed citations
14.
Bushinsky, David A., Patrick Rossignol, David M. Spiegel, et al.. (2016). Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis. American Journal of Nephrology. 44(5). 404–410. 38 indexed citations
16.
Knox, Renatta, Chong Zhao, Steven Wang, et al.. (2012). Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia–ischemia in mice with neuronal Fyn overexpression. Neurobiology of Disease. 51. 113–119. 45 indexed citations
17.
Toland, Amanda E., June M. Chan, Jinwei Yuan, Allan Balmain, & Jing Ma. (2004). A Gain of Function TGFB1 Polymorphism May Be Associated With Late Stage Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 13(5). 759–764. 54 indexed citations
18.
Toland, Amanda E., Paraskevi Briassouli, John P. de Koning, et al.. (2003). Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nature Genetics. 34(4). 403–412. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026